Poor efficacy of anti-programmed cell death-1/ligand 1 monotherapy for non-small cell lung cancer patients with active brain metastases.
Takehiro TozukaSatoru KitazonoHiroaki SakamotoHiroshi YoshidaYoshiaki AminoShinya UematsuTakahiro YoshizawaTsukasa HasegawaRyo AriyasuKen UchiboriNoriko YanagitaniTakeshi HoraiMasahiro SeikeAkihiko GemmaMakoto NishioPublished in: Thoracic cancer (2020)
Further studies on immunotherapy are needed for patients with active BMs.